1/458
Looks like no tags are added yet.
USP purpose
Establishes official standards for drug substances dosage forms and compounded preparations; ensures identity strength quality purity consistency.
NF purpose
Establishes standards for pharmaceutical excipients and inactive ingredients used in formulations.
Pharmaceutical dosage forms purpose
Protect from oxygen humidity gastric acid; mask taste odor; control release; enable topical inhalation rectal parenteral delivery; allow bloodstream access; improve swallowing.
External routes of administration
Oral sublingual buccal rectal.
Parenteral routes of administration
Injection nasal vaginal ophthalmic dermal topical transdermal inhalation.
Dosage form classifications
Solid tablets capsules powders; semisolid creams ointments gels; liquids syrups emulsions suspensions; gaseous inhalers nebulizers; specialized patches inserts implants.
Powders and granules
Fast action; more stable than liquids.
Regular tablets
Portable; ease of use.
Coated tablets
Taste and odor masking; easier swallowing.
Enteric coated tablets
Protect acid sensitive drugs.
Chewable tablets
Useful for swallowing difficulty; large drug loads.
Effervescent tablets
Rapid dissolution with CO2; faster onset.
Gummies
Improve compliance swallowing difficulty.
Sustained release tablets
Long acting therapy.
Lozenges
Dissolve slowly in mouth; avoid first pass metabolism.
Pastilles troches
Soft lozenges; slow dissolution.
Medicated gums
Buccal absorption; avoid first pass metabolism.
Fast disintegrating tablets and films
Dissolve rapidly; no water needed.
Sublingual dosage forms
Fast onset; avoid first pass metabolism.
Buccal dosage forms
Fast onset; avoid first pass metabolism.
Caplets
Tablet shaped like capsule; easier swallowing.
Hard gelatin capsules
Mask taste; faster action than tablets.
Sustained release capsules
Coated pellets; prolonged drug release.
Suppositories
Rectal vaginal urethral use; targeted delivery; non oral option.
Monophasic liquid dosage forms
Solutions syrups elixirs tinctures drops.
Biphasic liquid dosage forms
Suspensions solid liquid; emulsions liquid liquid.
Onset of action definition
Time required for drug to produce desired effect.
Onset of action ranking
IV
Biopharmaceutical considerations
Factors affecting absorption by route.
Drug factors in formulation
Physical and chemical properties.
Therapeutic considerations
Clinical indication and patient factors.
Plasticizers excipients
Provide elasticity and flexibility; examples castor oil PEG.
Binders excipients
Improve granule cohesion and flow; examples acacia PVP gelatin.
Disintegrants excipients
Draw water cause swelling and breakup; example starch.
Colorants excipients
Improve aesthetic appearance; FD and C dyes.
Physical drug excipient interactions
Complexation cyclodextrins; adsorption indomethacin; solid dispersions piroxicam norfloxacin ibuprofen.
Chemical drug excipient interactions
Reactions with excipients impurities residues.
Biopharmaceutical interactions
Observed after dosage form administration.
Preformulation physical parameters
Color odor taste particle size surface area flow density compressibility crystallinity hygroscopicity polymorphism.
Preformulation solubility parameters
Solubility ionization constant solubilization thermal effect common ion effect dissolution.
Preformulation stability parameters
Solid state stability solution stability drug excipient compatibility.
Preformulation chemical parameters
Hydrolysis oxidation photolysis chirality.
Hygroscopic substances
Absorb atmospheric moisture; affect stability.
Deliquescent substances
Absorb moisture liquefy leave water film.
Crystalline solids
Ordered molecular lattice.
Amorphous solids
No long range order; higher energy; higher aqueous solubility.
Drug concentration quantity per quantity
g per L mg per mL mg per volume.
Drug concentration percentage
% w v % w w % v v.
Drug concentration parts
Parts by weight of solids per parts by volume.
Drug concentration molarity
Mol per liter.
Drug concentration molality
Mol per kilogram.
Drug concentration mole fraction
Unitless.
Solubility enhancement chemical methods
Salt formation; prodrug formation.
Solubility enhancement physical methods
Particle size reduction cogrinding lipid formulations solubilization complexation carriers solid modification solid dispersion.
Noyes Whitney equation
dm dt = A D over h (Cs − Cb).
Factors increasing dissolution rate
Increased surface area; decreased particle size.
Dissolution rate ranking
Solution > suspension > capsule > tablet > coated tablet.
BCS Class I
High solubility high permeability; propranolol verapamil metoprolol.
BCS Class II
Low solubility high permeability; ketoprofen naproxen carbamazepine.
BCS Class III
High solubility low permeability; ranitidine cimetidine atenolol vancomycin.
BCS Class IV
Low solubility low permeability; furosemide hydrochlorothiazide.
Lipinski rule’s
molecular weight - ≤500 daltons.
H bond donors - ≤5.
H bond acceptors - ≤10.
logP - ≤5.
why we use it - a medicinal chemistry guideline that predicts whether a small molecule will have poor oral absorption and membrane permeability
can only deviate from one more than one it should not be used for oral
Lipinski rule exceptions
Transporter substrates antibiotics antifungals vitamins cardiac glycosides; applies to unionized drugs only.
Dry mixture oral solutions
Reconstituted with purified water; stable 7-14 days.
Extemporaneous oral solutions
Pediatric forms from adult products.
Oral rehydration solutions
Treat 5-10% dehydration; OTC.
Oral colonic lavage solution
Bowel prep; 4 L total; 240 mL every 10 min.
Magnesium citrate oral solution
Saline laxative; effervescent clear solution.
Sodium citrate citric acid solution
Systemic alkalinizer; maintains alkaline urine.
Purified water USP
Used for non parenteral preparations.
Water for injection USP
Sterile pyrogen free; used for parenterals.
Syrup definition
Concentrated aqueous sugar or sugar substitute solution.
Syrup NF
Eighty five percent w v sucrose; no flavor.
ORA Sweet syrups
Flavored vehicles; sugar free version available.
Sorbitol solution USP
Sweet bland syrup; pH 5-7.5; contains D sorbitol.
Elixir definition
Sweetened hydroalcoholic oral solution.
Phenobarbital elixir
Official elixir; 14% alcohol.
Theophylline elixir
20% alcohol.
Dexamethasone elixir
5% alcohol.
Digoxin elixir
Pediatric formulation; 10% alcohol.
Vintage elixir
38-40% alcohol; no longer marketed.
Syrups characteristics
Aqueous sweeter higher viscosity less stable better taste masking.
Elixirs characteristics
Hydroalcoholic less sweet lower viscosity more stable easier formulation.
Elixir preservative rule
Not required if alcohol >12% v v.
TDDS first order systems
Target organs tissues capillary beds.
TDDS second order systems
Target specific cell types.
TDDS third order systems
Target intracellular locations.
TDDS carrier classifications
Soluble macromolecules and particulate carriers.
TDDS active moiety
Purpose therapeutic effect.
TDDS carrier system
Purpose distribution protection reduced clearance.
TDDS homing device
Purpose cell or tissue targeting; not needed for passive targeting.
Liposome definition
Spherical vesicles with phospholipid bilayers.
Liposome phospholipids
Amphiphilic bilayer structure.
Liposome sterols
Modify fluidity permeability stability.
Liposome PEG
Prolong circulation; reduce metabolism.
Liposome charged lipids
Enable encapsulation and intracellular delivery.
Small unilamellar vesicles
20-100 nm; single bilayer.
Large unilamellar vesicles
100-1000 nm; single bilayer.
Giant unilamellar vesicles
≥1 µm; single bilayer.
Large multilamellar vesicles
200 nm-3 µm; multiple layers.